Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
The New England journal of medicine, 2015-05, Vol.372 (22), p.2127-2135
Ort / Verlag
United States: Massachusetts Medical Society
Erscheinungsjahr
2015
Link zum Volltext
Quelle
Alma/SFX Local Collection
Beschreibungen/Notizen
About one third of the world population has latent
M. tuberculosis
infection. This review explains the approach to patients with latent infection, including an update on the risks and benefits of treatment and assessment of the likelihood of progression to active disease.
The natural history of tuberculosis begins with the inhalation of
Mycobacterium tuberculosis
organisms; a period of bacterial replication and dissemination ensues, followed by immunologic containment of viable bacilli. The result of this process is asymptomatic latent tuberculosis infection, which is defined as a state of persistent bacterial viability, immune control, and no evidence of clinically manifested active tuberculosis.
1
Currently, it is not possible to directly diagnose
M. tuberculosis
infection in humans; therefore, latent tuberculosis infection is diagnosed by response to in vivo or in vitro stimulation by
M. tuberculosis
antigens with the use of the tuberculin skin test or interferon-γ . . .